Cargando…
Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma
The evolutionary trajectories of early lung adenocarcinoma (LUAD) have not been fully elucidated. We hypothesize that genomic analysis between pre-invasive and invasive components will facilitate the description of LUAD evolutionary patterns. We micro-dissect malignant pulmonary nodules (MPNs) into...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695730/ https://www.ncbi.nlm.nih.gov/pubmed/33247113 http://dx.doi.org/10.1038/s41467-020-19855-x |
_version_ | 1783615254265069568 |
---|---|
author | Wang, Siwei Du, Mulong Zhang, Jingyuan Xu, Weizhang Yuan, Qianyu Li, Ming Wang, Jie Zhu, Hongyu Wang, Yuzhuo Wang, Cheng Gong, Yuhua Wang, Xiaonan Hu, Zhibin Christiani, David C. Xu, Lin Shen, Hongbing Yin, Rong |
author_facet | Wang, Siwei Du, Mulong Zhang, Jingyuan Xu, Weizhang Yuan, Qianyu Li, Ming Wang, Jie Zhu, Hongyu Wang, Yuzhuo Wang, Cheng Gong, Yuhua Wang, Xiaonan Hu, Zhibin Christiani, David C. Xu, Lin Shen, Hongbing Yin, Rong |
author_sort | Wang, Siwei |
collection | PubMed |
description | The evolutionary trajectories of early lung adenocarcinoma (LUAD) have not been fully elucidated. We hypothesize that genomic analysis between pre-invasive and invasive components will facilitate the description of LUAD evolutionary patterns. We micro-dissect malignant pulmonary nodules (MPNs) into paired pre-invasive and invasive components for panel-genomic sequencing and recognize three evolutionary trajectories. Evolutionary mode 1 (EM1) demonstrates none of the common driver events between paired components, but another two modes, EM2A and EM2B, exhibit critical private alterations restricted to pre-invasive and invasive components, respectively. When ancestral clones harbor EGFR mutations, truncal mutation abundance significantly decrease after the acquisition of invasiveness, which may be associated with the intratumoral accumulation of infiltrated B cells. Harboring EGFR mutations is critical to the selective pressure and further impacts the prognosis. Our findings extend the understanding of evolutionary trajectories during invasiveness acquisition in early LUAD. |
format | Online Article Text |
id | pubmed-7695730 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-76957302020-12-03 Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma Wang, Siwei Du, Mulong Zhang, Jingyuan Xu, Weizhang Yuan, Qianyu Li, Ming Wang, Jie Zhu, Hongyu Wang, Yuzhuo Wang, Cheng Gong, Yuhua Wang, Xiaonan Hu, Zhibin Christiani, David C. Xu, Lin Shen, Hongbing Yin, Rong Nat Commun Article The evolutionary trajectories of early lung adenocarcinoma (LUAD) have not been fully elucidated. We hypothesize that genomic analysis between pre-invasive and invasive components will facilitate the description of LUAD evolutionary patterns. We micro-dissect malignant pulmonary nodules (MPNs) into paired pre-invasive and invasive components for panel-genomic sequencing and recognize three evolutionary trajectories. Evolutionary mode 1 (EM1) demonstrates none of the common driver events between paired components, but another two modes, EM2A and EM2B, exhibit critical private alterations restricted to pre-invasive and invasive components, respectively. When ancestral clones harbor EGFR mutations, truncal mutation abundance significantly decrease after the acquisition of invasiveness, which may be associated with the intratumoral accumulation of infiltrated B cells. Harboring EGFR mutations is critical to the selective pressure and further impacts the prognosis. Our findings extend the understanding of evolutionary trajectories during invasiveness acquisition in early LUAD. Nature Publishing Group UK 2020-11-27 /pmc/articles/PMC7695730/ /pubmed/33247113 http://dx.doi.org/10.1038/s41467-020-19855-x Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Wang, Siwei Du, Mulong Zhang, Jingyuan Xu, Weizhang Yuan, Qianyu Li, Ming Wang, Jie Zhu, Hongyu Wang, Yuzhuo Wang, Cheng Gong, Yuhua Wang, Xiaonan Hu, Zhibin Christiani, David C. Xu, Lin Shen, Hongbing Yin, Rong Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma |
title | Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma |
title_full | Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma |
title_fullStr | Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma |
title_full_unstemmed | Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma |
title_short | Tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma |
title_sort | tumor evolutionary trajectories during the acquisition of invasiveness in early stage lung adenocarcinoma |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695730/ https://www.ncbi.nlm.nih.gov/pubmed/33247113 http://dx.doi.org/10.1038/s41467-020-19855-x |
work_keys_str_mv | AT wangsiwei tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT dumulong tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT zhangjingyuan tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT xuweizhang tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT yuanqianyu tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT liming tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT wangjie tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT zhuhongyu tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT wangyuzhuo tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT wangcheng tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT gongyuhua tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT wangxiaonan tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT huzhibin tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT christianidavidc tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT xulin tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT shenhongbing tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma AT yinrong tumorevolutionarytrajectoriesduringtheacquisitionofinvasivenessinearlystagelungadenocarcinoma |